euronanomed.net

  • Increase font size
  • Default font size
  • Decrease font size

WORK PACKAGES
 
The EuroNanoMed coordination activities and management functions will be organised into five work packages (WP).
 
WP A:
 
SYSTEMATIC MAPPING OF THE ONGOING PROGRAMMES AND STRATEGIC AGENDA FOR JOINT ACTIVITIES
 
The primary aim of WP A is to provide information and systematic benchmarking activities on partnering programmes, to identify complementarities and barriers to joint activities and to raise solutions to overcome the barriers. This will lead to high quality policy information for national government officials towards their commitment of strategic development of the framework and the implementation of the two Joint transnational Calls for Applications. This will also be a basis for the strategic road map of EuroNanoMed activities.
WP A includes four main tasks:
  • Exchange of National information: initiation of regularly updated inventories of the characteristics and processes of the programmes of EuroNanoMed partner organizations;
  • Analysis of complementarities between partners and barriers for EuroNanoMed joint activities : Elaboration of a strategic agenda for EuroNanoMed joint activities ;
  • Definition of the strategic priorities for the two joint transnational Calls for applications;
  • Design a proposal for a future European programme on Nanomedicine beyond the lifetime of EuroNanoMed, taking advantage of the experience and lessons learned from other WP's.
WP B:
 
ESTABLISHMENT OF THE FRAMEWORK FOR THE 2 EURONANOMED JOINT TRANS-NATIONAL CALLS FOR PROPOSALS
 
Planning and executing of trans-national funding activities require agreements on themes of the planned projects and on all implementation and administrative issues concerned. WP B will provide the partners with a strong, commonly agreed framework and a joint funding scheme both being consistent with national legal applicable rules.
To develop this contractual framework, we will take advantage of pre-existing processes and documents from various running ERA-Net programmes as a basis to be adapted. In addition we will have to develop specific processes (e.g. selection criteria and guidelines for evaluators…etc).
There will be three main tasks:
  • To benchmark the joint trans-national calls used in other ERA-NETS, as a preliminary task;
  • To design the agreed framework and procedures for the two joint trans-national Calls for applications, including the design of the international peer review evaluation procedures;
  • To analyse the feed back from the first joint trans-national Call, to be used as an input for the planned second Call. 
WP C:
 
IMPLEMENTATION OF THE 2 EURONANOMED JOINT TRANS-NATIONAL CALLS FOR PROPOSALS
 
The objective of WP C is to implement 2 successive common joint trans-national calls for project proposals, based on the process, procedures and documents defined in WP B and the analysis of the lessons learned. Through a step-by-step coordination with two successive joint calls, the consortium will ensure the visibility of the integration process at policy maker’s level as well as in the scientific community.
There will be 3 main tasks:  
  • Set up and activation of a dedicated Call office;
  • Implementation of the common joint trans-national Call for project proposals according to the roadmap defined in WP A and the framework adopted in WP B. This will include the implementation of the common international peer reviewed evaluation procedure designed in WP B;
  • Dissemination to draw attention to EuroNanoMed calls when these are launched.
WP D:
 
NON-TECHNOLOGICAL INNOVATION BARRIERS
 
The main aim of WP D is to address non-technological innovation barriers for later industrial exploitation and market access as well as concerns about safety, ethical and social aspects of Nanomedicine. Within a global European market directed at the European level (EMEA) it is essential to address this issue at a European rather than at a national level. These activities will be carried out in close collaboration with WP A.
There will be 3 main tasks:
  • To identify, structure and prioritise the non-technological innovation barriers for a subfield of Nanomedicine (Diagnostics) by calling of an expert workshop and by collaborative work with stakeholders and other organizations (e.g. ETP Nanomedicine, EMEA);
  • To implement a Market-oriented Survey on the same subfield to suggest options to overcome these barriers;
  • Map Nanomedicine related safety issues.
WP E:
 
MANAGEMENT OF EURONANOMED AND SUPPORT
 
The Management of the coordination is a task to be implemented during the whole lifetime of the EuroNanoMed consortium. Specific infrastructure to run common activities, mainly the set up of an internal and external Website, will be created.  The EAB will be established.